Zürcher Kantonal Bank

Grand Resort Bad Ragaz is situated in the Heidiland holiday region of Eastern Switzerland. Europe’s leading wellbeing and medical health resort dates back to 1242. The health resort is supplemented by the renowned Medical Health Centre, as well as the Swiss Olympic Medical Center. The resort has two golf courses, the Kursaal Business & Events Center, a broad range of cultural activities, and its casino.

embotech AG, founded in 2013 and based in Zurich, Switzerland, specializes in developing software solutions for autonomous systems that focus on numerical optimization. Their flagship product, FORCES Pro, allows for the effective design of complex control systems by solving intricate optimization problems rapidly. The software has diverse applications, including the control of wind turbines, collision-free motion planning for autonomous drones, the enhancement of advanced driver assistance systems, and enabling precise landings for spacecraft on other planets, as well as the retrieval of reusable rockets. Embotech caters to various sectors, including automotive, energy, and robotics, positioning itself as a leader in creating advanced decision-making technologies essential for future autonomous systems.

Lymphatica Medtech SA is a Swiss company that specializes in the design and manufacture of medical devices aimed at treating lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed innovative solutions such as the LymphoDrain system, which includes an active implantable lymphatic bypass that integrates a magnetically controlled micropump and subcutaneous catheters. This technology is designed to re-establish lymphatic circulation by internally draining lymphatic fluid from multiple points in the affected limb, providing a minimally invasive remedy for patients suffering from lymphedema. Lymphatica Medtech's commitment to advancing treatment options in this field reflects its focus on improving patient outcomes through cutting-edge medical technology.

Complementa, established in 1984 and based in Saint Gallen, Switzerland, offers a range of services to support investors. These include consolidated performance reporting, accounting, investment consulting, and investment control. The company assists clients in planning, designing, and monitoring their investment and financing processes.

Synthara AG is a Swiss semiconductor startup specializing in the development of smart sensors for industrial Internet of Things (IoT) and energy-efficient applications. Founded in 2019 and headquartered in Zurich, the company focuses on creating advanced computational AI chips that enhance the performance of embedded systems. Its flagship product, ComputeRAM, functions as a drop-in replacement for traditional SRAM, enabling complex calculations directly in memory. This innovation significantly reduces CPU workload and enhances system efficiency, particularly for AI-driven applications. Synthara's technology is processor-type agnostic, compatible with various architectures including RISC-V, ARM, and x86, allowing seamless integration into existing microcontroller platforms. By offering solutions that lower costs and accelerate time to market, Synthara aims to empower chipmakers and device manufacturers to explore new opportunities in sectors such as wearables, biomedical monitoring, and autonomous navigation.

Microcaps AG is a company based in Zurich, Switzerland, founded in 2018, specializing in the development of advanced microencapsulation technology. The firm focuses on creating devices that facilitate the precise production of monodisperse microcapsules and microparticles through innovative microfluidics. Microcaps' solutions are designed to enhance drug delivery systems and probiotic encapsulation, while also providing tailored offerings for various applications, including pharmaceuticals and cosmetics. Their cutting-edge technology enables scalable, fully-automated production that allows for size control, precise dosing, and improved stability of the encapsulated materials. By utilizing a step emulsification device, Microcaps enhances production capacity and throughput rates without compromising quality, making it a pivotal player in the field of microencapsulation.

Bcomp Ltd. is a Fribourg-based manufacturer specializing in natural fiber composites, founded in 2003. The company produces a range of innovative products, including ampliTex, which utilizes natural flax fibers, bCores, a lightweight wood core, and powerRibs, a reinforcement material made from natural fibers. Bcomp's technologies are designed to replace traditional materials such as aluminum, carbon, or glass fiber composites, providing solutions that enhance weight efficiency, rigidity, shock absorption, and damping. The company serves various industries, including sports, automotive, acoustics, aerospace, electronics, design, and leisure. Bcomp has developed a robust portfolio of intellectual property, including patents and specific processing technologies derived from aerospace and marine applications. The company prioritizes collaboration with customers and academic partners to tailor its products to meet specific industry needs while advancing its research and development efforts.

Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform that utilizes magnetic blood purification technology to address infections and other health ailments. Hemotune's innovative approach involves the use of magnetic beads, which facilitate the selective and efficient removal of large biomolecules from the bloodstream. This technology focuses on the immunological aspects of conditions like sepsis, allowing for targeted treatment that addresses multiple disease pathways. By enhancing the purification of blood in acute care settings, Hemotune aims to improve patient outcomes for those suffering from blood-related diseases.

Odne is a medtech startup based in Renens, Switzerland, specializing in advanced implant technology for the field of endodontics. Founded in 2018, the company focuses on creating light-active medical fillers that facilitate the development of implants within the body through minimally invasive procedures. By utilizing an access channel of less than half a millimeter in diameter, Odne's technology allows physicians to perform surgeries that are not only time-efficient but also aim to deliver optimal patient outcomes. The innovative approach of using light-active fillers enhances the surgical process, positioning Odne as a forward-thinking player in the medical technology landscape.

Food Brewer AG is a Switzerland-based company specializing in the development and marketing of innovative food and food ingredients through the use of plant cell cultures. By employing technologies similar to beer brewing for large-scale cultivation in fermenters, Food Brewer provides sustainable alternatives to traditional agriculture. The company focuses on securing essential resources for the food industry while addressing geographic, climatic, and ethical uncertainties associated with conventional farming practices. Its product offerings include alternatives to cocoa, coffee, nuts, and grains, catering to the evolving needs of clients seeking sustainable food solutions.

Artiria Medical SA, established in 2019 and headquartered in Lausanne, Switzerland, specializes in developing innovative medical devices for treating vascular diseases. Its flagship product is a micro-actuated device designed to navigate deep into brain arteries, facilitating precise navigation and stroke treatment. This technology empowers catheters and guidewires, enabling surgeons to perform complex procedures with enhanced control and precision, ultimately saving lives.

Gerald Group is a prominent global commodity trading company that specializes in the physical merchanting, development, and trade of metal products and raw materials. Founded in 1962 and headquartered in Stamford, Connecticut, with additional offices in Morges, Switzerland, and Shanghai, China, the company provides a wide range of nonferrous and precious metals, including copper, aluminum, gold, and silver. Gerald Group serves various sectors, including metal producing, refining, smelting, and banking, by offering services such as commodity trading, logistics, storage, and risk management solutions. The company also engages in project financing, lending, and marketing strategy advisory. Through its strategic partnership with Pengxin International Mining Company, Gerald Group enhances its ability to deliver diverse resources to miners, processors, industrial consumers, and major financial institutions.

Aesyra SA is a Swiss company founded in 2017 and headquartered in Lausanne. It specializes in the design and manufacture of medical devices, particularly the AesyBite, an intra-oral sensor that monitors and alleviates sleep bruxism. Aesyra's technology is aimed at assisting dental professionals by reducing damage to dental prostheses caused by occlusal issues. The company focuses on enhancing the care of individuals with sleep disorders by providing tools that perform intraoral measurements during sleep. These measurements help in detecting bruxism, obstructive sleep apnea, and other related conditions. Through its innovative solutions, Aesyra enables healthcare professionals to accurately monitor patient activities and implement biofeedback treatments to improve sleep quality.

Nagi Bioscience SA is a Swiss company based in Lausanne that specializes in developing and manufacturing an innovative automated testing device utilizing organism-on-chip technology. This device leverages the microscopic worm Caenorhabditis elegans for in vivo testing, enabling pharmaceutical, chemical, and cosmetic companies to assess the toxic and beneficial effects of various substances. By integrating fully automated in vitro handling, culture, and analysis, Nagi Bioscience's platform facilitates toxicity testing, drug discovery, and anthelmintic testing. This approach allows clients to evaluate comprehensive biological responses that can only be observed at the level of the whole organism, thereby transforming traditional testing methodologies.

Hylomorph AG is a MedTech company based in Zurich, Switzerland, founded in 2014. The company specializes in the development of advanced biomaterials aimed at improving the interface between implantable medical devices and biological tissues. Hylomorph's innovative cellulose film is designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of postoperative complications such as fibrosis, infection, and device migration. This technology is particularly relevant for use in cardiac surgery and plastic surgery, addressing critical challenges associated with implant failure. By leveraging advanced biotech and surface micro-engineering methods, Hylomorph aims to enhance patient outcomes and optimize the quality of care provided by healthcare professionals.

UniSieve Ltd is a cleantech company based in Zurich, Switzerland, specializing in the development and manufacturing of mechanically flexible molecular sieving membranes. Founded in 2018, UniSieve utilizes a unique platform technology that combines various molecular sieves with polymeric membranes to create reliable separation solutions. These membranes are designed for a diverse array of applications, including chemical feedstock purification, biogas upgrading, gas and liquid separation, sensing, and space-related uses. By providing advanced molecular separation systems, UniSieve aims to enhance energy efficiency, reduce carbon dioxide emissions, and improve recycling rates for its clients, ultimately contributing to operational cost savings.

Nexoya AG is a Zurich-based company founded in 2018 that specializes in marketing analytics. The company offers a platform designed to provide insights into marketing data and actionable recommendations for enhancing marketing performance through artificial intelligence. By aggregating Key Performance Indicators from various tools such as Google Ads and Facebook, Nexoya's platform evaluates the optimal allocation of advertising budgets across different channels. The features of the platform include predictive analytics, cross-channel reporting, anomaly detection, and campaign optimization, all aimed at helping clients maximize their return on advertising spend and achieve better results from their marketing strategies.

Gerald Group is a prominent global commodity trading company that specializes in the physical merchanting, development, and trade of metal products and raw materials. Founded in 1962 and headquartered in Stamford, Connecticut, with additional offices in Morges, Switzerland, and Shanghai, China, the company provides a wide range of nonferrous and precious metals, including copper, aluminum, gold, and silver. Gerald Group serves various sectors, including metal producing, refining, smelting, and banking, by offering services such as commodity trading, logistics, storage, and risk management solutions. The company also engages in project financing, lending, and marketing strategy advisory. Through its strategic partnership with Pengxin International Mining Company, Gerald Group enhances its ability to deliver diverse resources to miners, processors, industrial consumers, and major financial institutions.

tado° GmbH is a technology company based in Munich, Germany, with an additional office in London, United Kingdom. Founded in 2010, it specializes in developing and marketing innovative home climate control systems that enhance the efficiency of heating and cooling in residential and small business environments. The company's products integrate a hardware-software combination that leverages real-time data on resident behavior, weather forecasts, and building characteristics to optimize climate management. tado° sells its solutions through both retail outlets and online platforms, effectively bringing Internet of Things technology to the cleantech market.

Medyria AG is a Swiss medical technology company focused on developing innovative sensor-based systems for catheter navigation and sensing in cardiovascular procedures. Founded in 2012 and based in Winterthur, Switzerland, Medyria engineers devices that enhance the safety and effectiveness of endovascular surgeries. Its product lineup includes a catheter positioning system that eliminates the need for X-rays and contrast dyes, a blood flow measurement system known as Flowcath, and the Trackcath technology, which processes flow data to facilitate catheter tracking. These technologies aim to streamline minimally invasive procedures, reduce potential complications, and lower overall treatment costs, thereby supporting healthcare professionals in delivering optimal patient care. Medyria operates with a commitment to advancing medical devices that prioritize patient safety and procedural efficiency.

Resistell AG is a Swiss company founded in 2018, based in Muttenz, specializing in the development and marketing of innovative diagnostic devices for antibiotic susceptibility testing. The company's platform employs advanced nanomotion technology to detect the movement of living bacterial cells, allowing for the rapid identification of bacterial resistance to antibiotics. This method serves as an alternative to traditional culture-based antibiograms, enabling healthcare providers to administer appropriate antibiotics in a timely manner, ultimately improving patient outcomes.

Skribble is an electronic signature platform founded in 2018 and headquartered in Zurich, Switzerland. It provides a legally compliant solution for signing contracts electronically, ensuring that digital signatures carry the same legal weight as handwritten signatures under Swiss and EU law. The platform facilitates the signing process by allowing users to upload documents and manage signatures between parties, all with just a few clicks. Skribble aims to simplify the contract signing experience while maintaining the necessary legal integrity, making it a valuable tool for individuals and businesses seeking efficient document management.

Invasight is a clinical biotech company based in Zurich, Switzerland, founded in 2019. The company specializes in advancing cell invasion research with the aim of accelerating the development of targeted therapies for invasive cancers. By focusing on the proteins involved in cancer cell invasion, Invasight aims to create therapies that minimize the side effects typically associated with conventional cancer treatments. This innovative approach seeks to provide cancer patients with effective and safe treatment options tailored to their specific needs.

Smeetz SA is a Swiss-based company that operates an online booking platform designed for the leisure and entertainment industry. Established in 2016 and headquartered in Lausanne, Smeetz offers an AI-powered commerce intelligence platform that integrates various tools for ticketing, payment processing, and event management. Its comprehensive solutions include features such as dynamic pricing, data analytics, reservation management, and cross-channel sales, all aimed at enhancing operational efficiency and maximizing revenue for venues. By leveraging insights derived from artificial intelligence, Smeetz empowers event organizers to optimize marketing strategies and improve guest experiences, thereby facilitating the digital transformation of the leisure sector.

Odne is a medtech startup based in Renens, Switzerland, specializing in advanced implant technology for the field of endodontics. Founded in 2018, the company focuses on creating light-active medical fillers that facilitate the development of implants within the body through minimally invasive procedures. By utilizing an access channel of less than half a millimeter in diameter, Odne's technology allows physicians to perform surgeries that are not only time-efficient but also aim to deliver optimal patient outcomes. The innovative approach of using light-active fillers enhances the surgical process, positioning Odne as a forward-thinking player in the medical technology landscape.

Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform that utilizes magnetic blood purification technology to address infections and other health ailments. Hemotune's innovative approach involves the use of magnetic beads, which facilitate the selective and efficient removal of large biomolecules from the bloodstream. This technology focuses on the immunological aspects of conditions like sepsis, allowing for targeted treatment that addresses multiple disease pathways. By enhancing the purification of blood in acute care settings, Hemotune aims to improve patient outcomes for those suffering from blood-related diseases.

Sleepiz AG, founded in 2018 and headquartered in Zurich, Switzerland, specializes in manufacturing a non-contact sleep disorder-screening device. The product monitors breathing, heart rate, and body movements with medical-grade accuracy using wireless millimeter wave technology, sensor fusion, and artificial intelligence. This device is designed to be placed on the bedside table for easy use, enabling healthcare professionals to monitor patients' sleep patterns from home. Sleepiz aims to facilitate long-term monitoring of chronic diseases, allowing for faster intervention and improved treatment outcomes.

9T Labs AG, founded in 2018 and based in Zürich, Switzerland, specializes in the manufacture of 3D printers that produce carbon fiber composites. The company integrates advanced software, additive manufacturing, and industry-standard materials to offer a digital composite production solution. Its proprietary Additive Fusion Technology enables the creation of lightweight structural parts with precise fiber orientation, allowing for the mass production of carbon composites at reduced costs. The intuitive design software facilitates optimal fiber placement, while automated production equipment enhances efficiency and competitiveness across the manufacturing value chain. 9T Labs’ technology simplifies the production of performance parts, making them more accessible for various applications, including drones and prosthetics.

Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.

Odne is a medtech startup based in Renens, Switzerland, specializing in advanced implant technology for the field of endodontics. Founded in 2018, the company focuses on creating light-active medical fillers that facilitate the development of implants within the body through minimally invasive procedures. By utilizing an access channel of less than half a millimeter in diameter, Odne's technology allows physicians to perform surgeries that are not only time-efficient but also aim to deliver optimal patient outcomes. The innovative approach of using light-active fillers enhances the surgical process, positioning Odne as a forward-thinking player in the medical technology landscape.

Nanoleq AG is a Swiss company founded in 2017 and based in Zurich, specializing in the development and manufacture of electric cables utilizing stretchable electronics. As a spinoff from ETH Zurich, Nanoleq focuses on integrating electronic functionality into textiles, particularly for health monitoring. The company creates soft sensors that can track vital signs such as heart rate, electrocardiograms, and breathing patterns through washable and comfortable garments. Their innovative conductive silicone technology allows for the monitoring of various physiological parameters while maintaining user comfort. Nanoleq aims to establish a standard for health-monitoring textiles, making significant strides in sectors such as healthcare, robotics, aerospace, and general electronics, while also working on further advancements in textile sensor technology.

Hylomorph AG is a MedTech company based in Zurich, Switzerland, founded in 2014. The company specializes in the development of advanced biomaterials aimed at improving the interface between implantable medical devices and biological tissues. Hylomorph's innovative cellulose film is designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of postoperative complications such as fibrosis, infection, and device migration. This technology is particularly relevant for use in cardiac surgery and plastic surgery, addressing critical challenges associated with implant failure. By leveraging advanced biotech and surface micro-engineering methods, Hylomorph aims to enhance patient outcomes and optimize the quality of care provided by healthcare professionals.

xorlab AG is a Swiss cybersecurity firm founded in 2015 and based in Zurich. The company specializes in developing advanced cyber defense solutions, notably its ActiveGuard platform, which protects corporate communication from sophisticated threats such as spear-phishing, ransomware, and zero-day exploits. By leveraging machine intelligence, xorlab enables organizations to detect and neutralize targeted email attacks effectively. With a dedicated team of 14 security professionals and software engineers, xorlab currently safeguards over 50,000 mailboxes, processing more than 1.5 million emails daily for clients in the financial and high-tech sectors in Germany and Switzerland. Through its innovative technologies, xorlab aims to reduce the risk of security breaches and lower operational costs for its customers.

Seervision AG is a Swiss startup founded in 2016 and based in Zurich, specializing in software for camera automation aimed at enhancing video production. Originally conceived at ETH Zurich to improve live lecture recording, the company has evolved into a robust enterprise with a focus on automating workflows in corporate studios, stage events, and educational environments. The Seervision Suite employs advanced video analysis algorithms that utilize motion control technology, integrating computer vision and machine learning to facilitate fully automated productions. This includes features such as autonomous camera tracking, facial recognition, and scene understanding, allowing for seamless integration into corporate settings and significantly simplifying live production processes. With a growing team of over 30 employees, Seervision is committed to making video production effortless and efficient.

Scewo AG, founded in 2017 and headquartered in Winterthur, Switzerland, specializes in the design and manufacture of innovative electric wheelchairs tailored for individuals with mobility impairments. The company has developed a unique stair-climbing wheelchair that features a combination of wheels and tracks, which allows users to navigate various terrains and obstacles, including curbs and uneven surfaces. With an active control system that ensures stability and balance, the wheelchair can be operated through a joystick or a shift in body weight, enabling users to maintain independence and enhance their mobility in everyday life.

Sleepiz AG, founded in 2018 and headquartered in Zurich, Switzerland, specializes in manufacturing a non-contact sleep disorder-screening device. The product monitors breathing, heart rate, and body movements with medical-grade accuracy using wireless millimeter wave technology, sensor fusion, and artificial intelligence. This device is designed to be placed on the bedside table for easy use, enabling healthcare professionals to monitor patients' sleep patterns from home. Sleepiz aims to facilitate long-term monitoring of chronic diseases, allowing for faster intervention and improved treatment outcomes.

RoomPriceGenie AG, founded in 2017 and based in Steinhausen, Switzerland, specializes in designing and developing revenue management software tailored for hotels, apartments, and vacation rentals. The company's platform offers sophisticated yielding, strategy foresight, and automated updates to optimize room pricing based on demand, occupancy, and availability. By leveraging advanced dynamic pricing algorithms and real-time analytics, RoomPriceGenie ensures optimal pricing strategies. It integrates seamlessly with various property management systems and channel managers, providing both automated pricing adjustments and manual control options. This makes it a versatile tool for small to medium-sized hotels aiming to boost their revenue efficiently. The platform is known for its user-friendly interface and excellent customer support.

ELDICO Scientific AG is a Swiss company founded in 2019 and located at the Switzerland Innovation Park Innovaare, which is affiliated with the Paul Scherrer Institute. The company specializes in the development, manufacturing, and sale of electron diffractometers designed for the analysis of solid compounds, particularly targeting nano-crystalline systems in the sub-micrometer range. ELDICO's innovative instruments enable industrial and scientific researchers to characterize materials that were previously challenging to measure, thereby facilitating advancements in fields such as pharmaceuticals, agrochemicals, and advanced materials research. The company achieved proof of concept for its technology in 2018, with recognition from reputable scientific communities, including being named a Top 5 "Breakthrough of the Year" by a leading journal. This groundbreaking work positions ELDICO as a key player in enhancing the speed and cost-effectiveness of structural analysis, ultimately contributing to faster drug discovery and development processes.

Qnami AG is a Swiss company that specializes in the development of quantum sensing technologies for non-invasive magnetic imaging at the nanoscale. Founded in 2017 and based in Basel, Qnami's flagship products include the ProteusQ, a magnetic imaging microscope, and the Quantum Diamond, which features diamond probes with a single nitrogen-vacancy center for high-resolution imaging. These technologies allow for advanced applications in various fields, including multiferroic antiferromagnets, magnetic random-access memory (MRAM), and superconductivity. By enabling researchers and industries to measure electric and magnetic fields with exceptional sensitivity, Qnami enhances the capabilities of imaging techniques and supports groundbreaking scientific studies and industrial advancements.

Nexoya AG is a Zurich-based company founded in 2018 that specializes in marketing analytics. The company offers a platform designed to provide insights into marketing data and actionable recommendations for enhancing marketing performance through artificial intelligence. By aggregating Key Performance Indicators from various tools such as Google Ads and Facebook, Nexoya's platform evaluates the optimal allocation of advertising budgets across different channels. The features of the platform include predictive analytics, cross-channel reporting, anomaly detection, and campaign optimization, all aimed at helping clients maximize their return on advertising spend and achieve better results from their marketing strategies.

Apiax AG is a Swiss company founded in 2017, with offices in Zürich, Lisbon, and London, specializing in digital compliance solutions for the financial sector. It enables banks and FinTech companies to convert complex regulatory requirements into straightforward digital compliance rules. By leveraging machine learning and a high-performance architecture, Apiax provides an embedded compliance solution that allows financial institutions to integrate compliance seamlessly into their existing workflows and applications. This innovative approach helps organizations address regulatory challenges, capitalize on business opportunities, and reduce compliance costs, ultimately enhancing their operational efficiency and decision-making processes.

Microcaps AG is a company based in Zurich, Switzerland, founded in 2018, specializing in the development of advanced microencapsulation technology. The firm focuses on creating devices that facilitate the precise production of monodisperse microcapsules and microparticles through innovative microfluidics. Microcaps' solutions are designed to enhance drug delivery systems and probiotic encapsulation, while also providing tailored offerings for various applications, including pharmaceuticals and cosmetics. Their cutting-edge technology enables scalable, fully-automated production that allows for size control, precise dosing, and improved stability of the encapsulated materials. By utilizing a step emulsification device, Microcaps enhances production capacity and throughput rates without compromising quality, making it a pivotal player in the field of microencapsulation.

Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform that utilizes magnetic blood purification technology to address infections and other health ailments. Hemotune's innovative approach involves the use of magnetic beads, which facilitate the selective and efficient removal of large biomolecules from the bloodstream. This technology focuses on the immunological aspects of conditions like sepsis, allowing for targeted treatment that addresses multiple disease pathways. By enhancing the purification of blood in acute care settings, Hemotune aims to improve patient outcomes for those suffering from blood-related diseases.

Artiria Medical SA, established in 2019 and headquartered in Lausanne, Switzerland, specializes in developing innovative medical devices for treating vascular diseases. Its flagship product is a micro-actuated device designed to navigate deep into brain arteries, facilitating precise navigation and stroke treatment. This technology empowers catheters and guidewires, enabling surgeons to perform complex procedures with enhanced control and precision, ultimately saving lives.

Metaco is a Swiss company that specializes in providing digital asset management solutions for financial institutions. It offers a comprehensive orchestration platform that allows institutions to issue, secure, manage, and trade a diverse range of digital assets, including cryptocurrencies, tokens, and smart contracts. The company’s platform supports the entire lifecycle of asset tokens with a robust smart contract framework, facilitating the management of various asset classes such as equities, bonds, and derivatives. Metaco's technology ensures a secure and agile digital asset vault for self-custody, while also providing connectivity to over 50 exchanges, brokers, and market makers, thus enabling seamless trading and efficient risk management for its clients.

Positrigo AG is a Zurich-based company specializing in the development, manufacturing, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on providing functional imaging solutions that facilitate the early detection of neurodegenerative diseases, particularly Alzheimer's disease, as well as other conditions like Lewy body dementia, vascular dementia, and frontotemporal dementia. The company's PET scanners are designed to be accessible and affordable, enabling healthcare professionals to diagnose and monitor treatment effectively, while also contributing to the advancement of new therapies in the field of neurology.

xorlab AG is a Swiss cybersecurity firm founded in 2015 and based in Zurich. The company specializes in developing advanced cyber defense solutions, notably its ActiveGuard platform, which protects corporate communication from sophisticated threats such as spear-phishing, ransomware, and zero-day exploits. By leveraging machine intelligence, xorlab enables organizations to detect and neutralize targeted email attacks effectively. With a dedicated team of 14 security professionals and software engineers, xorlab currently safeguards over 50,000 mailboxes, processing more than 1.5 million emails daily for clients in the financial and high-tech sectors in Germany and Switzerland. Through its innovative technologies, xorlab aims to reduce the risk of security breaches and lower operational costs for its customers.

Skribble is an electronic signature platform founded in 2018 and headquartered in Zurich, Switzerland. It provides a legally compliant solution for signing contracts electronically, ensuring that digital signatures carry the same legal weight as handwritten signatures under Swiss and EU law. The platform facilitates the signing process by allowing users to upload documents and manage signatures between parties, all with just a few clicks. Skribble aims to simplify the contract signing experience while maintaining the necessary legal integrity, making it a valuable tool for individuals and businesses seeking efficient document management.

PXL Vision AG, established in 2017 and headquartered in Zurich, Switzerland, specializes in designing and developing advanced identity verification software solutions. Its flagship product, Daego, is a cross-platform solution that creates trusted digital identities for customer onboarding through sophisticated document and identity verification using computer vision and machine learning technologies. PXL Vision operates research and development centers in Novi Sad, Serbia, and Yerevan, Armenia, serving industries such as insurance, gambling, fintech, banking, and healthcare worldwide. The company aims to reduce customer onboarding costs, enhance conversion rates, and prevent fraud by providing unbiased, verifiable identities for secure digital interactions.

Klepsydra Technologies GmbH is a software development company based in Zurich, Switzerland, founded in 2017. It specializes in providing a lightweight, platform-agnostic software engineering toolset designed for embedded systems. The company’s software facilitates the development of high-performance applications across various sectors, including aerospace, robotics, autonomous unmanned aerial vehicles, smart mobility, and Internet of Things (IoT) solutions. By offering a cloud computing tool, Klepsydra enables clients to accelerate the development of complex embedded software while optimizing computational performance for demanding tasks such as sensor fusion and image processing. This positions Klepsydra as a versatile enabler of innovation, helping clients achieve ambitious goals through enhanced efficiency and effectiveness in their engineering processes.

Nagi Bioscience SA is a Swiss company based in Lausanne that specializes in developing and manufacturing an innovative automated testing device utilizing organism-on-chip technology. This device leverages the microscopic worm Caenorhabditis elegans for in vivo testing, enabling pharmaceutical, chemical, and cosmetic companies to assess the toxic and beneficial effects of various substances. By integrating fully automated in vitro handling, culture, and analysis, Nagi Bioscience's platform facilitates toxicity testing, drug discovery, and anthelmintic testing. This approach allows clients to evaluate comprehensive biological responses that can only be observed at the level of the whole organism, thereby transforming traditional testing methodologies.

Resistell AG is a Swiss company founded in 2018, based in Muttenz, specializing in the development and marketing of innovative diagnostic devices for antibiotic susceptibility testing. The company's platform employs advanced nanomotion technology to detect the movement of living bacterial cells, allowing for the rapid identification of bacterial resistance to antibiotics. This method serves as an alternative to traditional culture-based antibiograms, enabling healthcare providers to administer appropriate antibiotics in a timely manner, ultimately improving patient outcomes.

Qnami AG is a Swiss company that specializes in the development of quantum sensing technologies for non-invasive magnetic imaging at the nanoscale. Founded in 2017 and based in Basel, Qnami's flagship products include the ProteusQ, a magnetic imaging microscope, and the Quantum Diamond, which features diamond probes with a single nitrogen-vacancy center for high-resolution imaging. These technologies allow for advanced applications in various fields, including multiferroic antiferromagnets, magnetic random-access memory (MRAM), and superconductivity. By enabling researchers and industries to measure electric and magnetic fields with exceptional sensitivity, Qnami enhances the capabilities of imaging techniques and supports groundbreaking scientific studies and industrial advancements.

Apiax AG is a Swiss company founded in 2017, with offices in Zürich, Lisbon, and London, specializing in digital compliance solutions for the financial sector. It enables banks and FinTech companies to convert complex regulatory requirements into straightforward digital compliance rules. By leveraging machine learning and a high-performance architecture, Apiax provides an embedded compliance solution that allows financial institutions to integrate compliance seamlessly into their existing workflows and applications. This innovative approach helps organizations address regulatory challenges, capitalize on business opportunities, and reduce compliance costs, ultimately enhancing their operational efficiency and decision-making processes.

Picstars AG, established in 2014 and headquartered in Zürich, Switzerland, operates an online platform that connects brands with suitable influencers, particularly in the sports and lifestyle sectors. The company's core service involves helping brands identify and collaborate with appropriate brand ambassadors who can promote their products or services through their own social media channels. Picstars' platform enables brands to create and manage campaigns, track performance, and measure the success of their influencer marketing efforts. Recognized as one of the top 10 tech startups in Switzerland, Picstars aims to digitize the sponsorship of brand ambassadors, streamlining the process for both brands and influencers.

Yonder AG is a Swiss company based in Zurich, founded in 2015, that specializes in documentation-as-a-service (DaaS) solutions. The company's flagship offering, Yonder Mind, is an application designed for efficient information management, enabling organizations to create, maintain, and deliver information effectively to users. Yonder AG focuses on streamlining the documentation process by providing shorter, more relevant documents and manageable revisions, alongside services for document content creation and conversion. Through its innovative solutions, Yonder AG aims to enhance the way businesses handle their information needs.

Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, Versantis aims to address significant unmet medical needs for patients globally. Its lead candidate, VS-01, is currently in preclinical development and has the potential to be the first treatment for acute liver disease while simultaneously supporting multiple failing organs. VS-01 has received Orphan Drug Designation for its application in acute liver failure. The company also has additional treatments in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent substantial market opportunities and underscore Versantis' commitment to improving patient outcomes for millions affected by liver conditions and related disorders.

xorlab AG is a Swiss cybersecurity firm founded in 2015 and based in Zurich. The company specializes in developing advanced cyber defense solutions, notably its ActiveGuard platform, which protects corporate communication from sophisticated threats such as spear-phishing, ransomware, and zero-day exploits. By leveraging machine intelligence, xorlab enables organizations to detect and neutralize targeted email attacks effectively. With a dedicated team of 14 security professionals and software engineers, xorlab currently safeguards over 50,000 mailboxes, processing more than 1.5 million emails daily for clients in the financial and high-tech sectors in Germany and Switzerland. Through its innovative technologies, xorlab aims to reduce the risk of security breaches and lower operational costs for its customers.

Wingtra AG is a Swiss company specializing in the manufacturing of vertical take-off and landing (VTOL) drones, particularly the WingtraOne model. Founded in 2014 and headquartered in Zürich, WingtraOne is designed for high-precision aerial data collection, serving various industries such as surveying, agriculture, forestry, and infrastructure. Since its introduction to the market in 2017, the drone has gained recognition for its capability to facilitate the digitization of environments, particularly for surveying professionals in sectors including construction, mining, environmental monitoring, and urban planning. Wingtra has established partnerships with over 50 leading surveying equipment dealers worldwide, enhancing its presence in the global market. The drone operates with WingtraPilot software, enabling users to collect survey-grade aerial data that can be transformed into detailed two-dimensional maps and three-dimensional models, thereby providing valuable insights for monitoring and inspection activities across multiple industries.

Eyeware Tech SA, established in 2016 in Martigny, Switzerland, specializes in developing software for eye tracking using standard webcams and 3D cameras. Its flagship product, GazeSense, enables accurate gaze tracking, facilitating applications across industries such as automotive, healthcare, gaming, and robotics. Eyeware's platform-independent technology improves upon previous hardware-based solutions by offering a cost-effective and reliable alternative for integrating head and eye tracking into consumer devices.

xorlab AG is a Swiss cybersecurity firm founded in 2015 and based in Zurich. The company specializes in developing advanced cyber defense solutions, notably its ActiveGuard platform, which protects corporate communication from sophisticated threats such as spear-phishing, ransomware, and zero-day exploits. By leveraging machine intelligence, xorlab enables organizations to detect and neutralize targeted email attacks effectively. With a dedicated team of 14 security professionals and software engineers, xorlab currently safeguards over 50,000 mailboxes, processing more than 1.5 million emails daily for clients in the financial and high-tech sectors in Germany and Switzerland. Through its innovative technologies, xorlab aims to reduce the risk of security breaches and lower operational costs for its customers.

TOLREMO therapeutics AG is a biotechnology company based in Muttenz, Switzerland, specializing in the development of small molecule therapies aimed at addressing drug resistance in cancer treatment. Founded in 2017, TOLREMO focuses on creating innovative drug discovery engines and therapies that target novel resistance pathways in cancer cells. The company’s approach involves developing add-on therapies that enhance the effectiveness of existing oncogene-targeting drugs by dismantling the initial defenses against these treatments. By specifically targeting and eradicating cancer cells responsible for drug resistance, TOLREMO aims to provide personalized anti-drug resistance therapies that significantly prolong the lives of cancer patients and improve treatment response rates.

Hylomorph AG is a MedTech company based in Zurich, Switzerland, founded in 2014. The company specializes in the development of advanced biomaterials aimed at improving the interface between implantable medical devices and biological tissues. Hylomorph's innovative cellulose film is designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of postoperative complications such as fibrosis, infection, and device migration. This technology is particularly relevant for use in cardiac surgery and plastic surgery, addressing critical challenges associated with implant failure. By leveraging advanced biotech and surface micro-engineering methods, Hylomorph aims to enhance patient outcomes and optimize the quality of care provided by healthcare professionals.

Climeworks AG is a Swiss company founded in 2009 that specializes in developing and commercializing technology for capturing carbon dioxide (CO2) directly from the atmosphere. The company operates modular direct air capture plants that utilize filters and primarily low-grade heat as an energy source to extract CO2. This captured CO2 is then supplied to various industries, including commercial agriculture, food and beverage, energy, and automotive. Clients employ this atmospheric CO2 for applications such as carbonated drinks, carbon-neutral hydrocarbon fuels, and materials. Climeworks also supports businesses in achieving their climate objectives by providing solutions for reversing emissions and safely storing the captured CO2, contributing to global efforts to combat climate change.

ProteoMediX is a healthcare company based in Zurich-Schlieren, Switzerland, focused on transforming the diagnosis of prostate cancer. The company has developed innovative biomarker signatures that enhance the accuracy of prostate cancer diagnosis, prognosis, and therapy management. Its lead product, Proclarix®, is a blood-based test panel and risk score that is currently available in Europe. The biomarkers created by ProteoMediX provide improved discrimination between aggressive and indolent forms of cancer, surpassing existing clinical standards. This advancement enables physicians to make more informed treatment decisions for their patients, ultimately aiming to improve outcomes in prostate cancer care.

Aspivix SA is a Swiss company founded in 2015, specializing in the development of minimally invasive surgical instruments for gynecology. Headquartered in Lausanne, the firm focuses on creating a new generation of medical devices that enhance the safety and comfort of gynecological procedures. Its flagship product, CAREVIX, employs innovative suction technology to facilitate the painless placement of intra-uterine contraceptive devices and other gynecological interventions. This device is specifically designed to reduce cervical bleeding and minimize the risk of lesions and cross-infections, ultimately safeguarding patient health. By replacing traditional methods such as the use of forceps with its patented suction pad technology, Aspivix aims to transform gynecological care, providing gentler solutions for both women and healthcare providers.

Uepaa AG, based in Zurich, Switzerland, specializes in peer-to-peer communication technology for mobile devices. Founded in 2012 by Mathias Haussmann and Dr. Franck Legendre, the company has developed an innovative software solution that allows mobile applications to establish direct connections, even in the absence of cellular or internet coverage. Its flagship product, the Uepaa! Safety app, launched in 2013, is designed to provide safety protection for lone workers and field employees by enabling features such as accident detection and emergency alerts. This app has become an industry standard for mobile-based safety solutions, serving thousands of users and meeting the growing demand for enhanced worker safety in various environments. Uepaa AG's technology platform, known as Proximity SDK p2pkit, allows devices to communicate and share information when in close proximity, further enhancing its applications in safety and emergency response.

TestingTime AG is a Swiss company founded in 2014 and based in Zurich, specializing in online test user recruitment for usability studies, focus groups, interviews, and surveys. The company serves the UX and market research sectors by providing access to a diverse pool of over 350,000 test users, facilitating the selection of participants tailored to specific research needs. TestingTime employs online campaigns and referral strategies to acquire test users, while utilizing a smart rating system and predictive machine learning algorithms to ensure high-quality participants with a low no-show rate. Its services are offered in multiple languages, including German, French, Italian, Romansh, and English. TestingTime's platform enables large corporations, such as UBS, Zalando, Microsoft, and Accenture, to conduct qualitative and quantitative user research efficiently, enhancing their ability to gather valuable insights.

Polyneuron Pharmaceuticals AG is a biopharmaceutical company based in Basel, Switzerland, focused on developing innovative therapeutics for the treatment of autoimmune disorders. Founded in 2014, the company specializes in creating drugs to target specific autoimmune conditions, including PN-1007 for anti-MAG neuropathy, PN-1018 for multifocal motor neuropathy, and PN-032 and PN-056 for ABO-incompatible transplantation. Polyneuron's therapeutic approach employs biodegradable glycopolymers that selectively eliminate pathological autoantibodies, preserving the overall integrity of the immune system. This technology, referred to as Antibody-Catch, aims to provide safe and effective treatment options for patients suffering from autoimmune diseases affecting the peripheral nervous system, particularly those involving autoantibodies against carbohydrate epitopes.

Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.

Abionic SA is a biotechnology company based in Lausanne, Switzerland, specializing in revolutionary nanotechnology-based diagnostic solutions. Founded in 2010 as a spin-off from the Swiss Federal Institute of Technology Lausanne (EPFL), the company develops a biomedical screening platform called abioSCOPE, which allows healthcare professionals to conduct tests using a single drop of blood in a remarkably short time. This platform includes abioSCOPE, a reader for testing nanofluidic sensors, and abioGUIDE, a smartphone and tablet application for enhanced usability. Abionic's products focus on improving medical diagnoses, particularly in allergy detection and sepsis management. The company is committed to personalized medicine and operates under ISO 9001/13485 certifications, ensuring adherence to rigorous quality management standards for medical devices. With support from the EPFL, the Canton of Vaud, and Venturelab, Abionic aims to establish itself as a significant player in the global medical technology landscape.

Piavita AG, founded in 2016 and headquartered in Zurich, Switzerland, specializes in developing advanced technology for the veterinary industry. The company has created a compact, matchbox-sized wearable device that accurately measures vital medical data from pets, including horses, without the need for clipping fur or extensive preparation. This innovative system is complemented by a web-based application that enables real-time monitoring and historical tracking of vital signs, improving the diagnostic capabilities available to veterinarians. By providing reliable insights into pet health and facilitating better communication between pet owners and veterinary professionals, Piavita aims to lead the digital transformation of veterinary care, addressing the gaps in current veterinary practices and enhancing the overall wellbeing of animals.

Picstars AG, established in 2014 and headquartered in Zürich, Switzerland, operates an online platform that connects brands with suitable influencers, particularly in the sports and lifestyle sectors. The company's core service involves helping brands identify and collaborate with appropriate brand ambassadors who can promote their products or services through their own social media channels. Picstars' platform enables brands to create and manage campaigns, track performance, and measure the success of their influencer marketing efforts. Recognized as one of the top 10 tech startups in Switzerland, Picstars aims to digitize the sponsorship of brand ambassadors, streamlining the process for both brands and influencers.

embotech AG, founded in 2013 and based in Zurich, Switzerland, specializes in developing software solutions for autonomous systems that focus on numerical optimization. Their flagship product, FORCES Pro, allows for the effective design of complex control systems by solving intricate optimization problems rapidly. The software has diverse applications, including the control of wind turbines, collision-free motion planning for autonomous drones, the enhancement of advanced driver assistance systems, and enabling precise landings for spacecraft on other planets, as well as the retrieval of reusable rockets. Embotech caters to various sectors, including automotive, energy, and robotics, positioning itself as a leader in creating advanced decision-making technologies essential for future autonomous systems.

QualySense AG is a Swiss company specializing in the development and marketing of advanced sorting devices for grains, seeds, and beans. Founded in 2009 and based in Glattbrugg, Switzerland, the company has created innovative high-throughput sorting technology that assesses the biochemical quality of individual kernels. Its flagship product, the QSorter Explorer, facilitates the sorting and measurement of multiple properties of grains, seeds, and beans in a single pass, allowing users to categorize these products based on various quality metrics. QualySense's technology employs hyperspectral near-infrared spectroscopy and machine vision to analyze compositional attributes such as oil, protein, and moisture, as well as physical characteristics like shape, size, and color. The company's solutions are designed for seed breeders, food processors, and inspection agencies, enabling clients to enhance product quality, optimize processes, and maximize the economic value of their agricultural products.

Apiax AG is a Swiss company founded in 2017, with offices in Zürich, Lisbon, and London, specializing in digital compliance solutions for the financial sector. It enables banks and FinTech companies to convert complex regulatory requirements into straightforward digital compliance rules. By leveraging machine learning and a high-performance architecture, Apiax provides an embedded compliance solution that allows financial institutions to integrate compliance seamlessly into their existing workflows and applications. This innovative approach helps organizations address regulatory challenges, capitalize on business opportunities, and reduce compliance costs, ultimately enhancing their operational efficiency and decision-making processes.

Peripal AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in developing and distributing innovative medical devices designed to assist patients undergoing Peritoneal Dialysis at home. Their flagship product, PeriSafe, is a patient-assist device that simplifies the process of connecting dialysis tubings manually, reducing the risk of infection and requiring less dexterity from users. Additionally, they offer PERiPLEX, a diagnostic tool for detecting infections in peritoneal dialysis patients. Peripal's primary focus is on developing products like the Peripal System to support chronic home care patients, aiming to enhance their quality of life while reducing healthcare costs.

Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, Versantis aims to address significant unmet medical needs for patients globally. Its lead candidate, VS-01, is currently in preclinical development and has the potential to be the first treatment for acute liver disease while simultaneously supporting multiple failing organs. VS-01 has received Orphan Drug Designation for its application in acute liver failure. The company also has additional treatments in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent substantial market opportunities and underscore Versantis' commitment to improving patient outcomes for millions affected by liver conditions and related disorders.

ProteoMediX is a healthcare company based in Zurich-Schlieren, Switzerland, focused on transforming the diagnosis of prostate cancer. The company has developed innovative biomarker signatures that enhance the accuracy of prostate cancer diagnosis, prognosis, and therapy management. Its lead product, Proclarix®, is a blood-based test panel and risk score that is currently available in Europe. The biomarkers created by ProteoMediX provide improved discrimination between aggressive and indolent forms of cancer, surpassing existing clinical standards. This advancement enables physicians to make more informed treatment decisions for their patients, ultimately aiming to improve outcomes in prostate cancer care.

Piavita AG, founded in 2016 and headquartered in Zurich, Switzerland, specializes in developing advanced technology for the veterinary industry. The company has created a compact, matchbox-sized wearable device that accurately measures vital medical data from pets, including horses, without the need for clipping fur or extensive preparation. This innovative system is complemented by a web-based application that enables real-time monitoring and historical tracking of vital signs, improving the diagnostic capabilities available to veterinarians. By providing reliable insights into pet health and facilitating better communication between pet owners and veterinary professionals, Piavita aims to lead the digital transformation of veterinary care, addressing the gaps in current veterinary practices and enhancing the overall wellbeing of animals.

Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.

Polyneuron Pharmaceuticals AG is a biopharmaceutical company based in Basel, Switzerland, focused on developing innovative therapeutics for the treatment of autoimmune disorders. Founded in 2014, the company specializes in creating drugs to target specific autoimmune conditions, including PN-1007 for anti-MAG neuropathy, PN-1018 for multifocal motor neuropathy, and PN-032 and PN-056 for ABO-incompatible transplantation. Polyneuron's therapeutic approach employs biodegradable glycopolymers that selectively eliminate pathological autoantibodies, preserving the overall integrity of the immune system. This technology, referred to as Antibody-Catch, aims to provide safe and effective treatment options for patients suffering from autoimmune diseases affecting the peripheral nervous system, particularly those involving autoantibodies against carbohydrate epitopes.

Fanpictor is a Swiss technology company specializing in innovative digital and on-site fan engagement solutions for brands and rights holders. The company creates immersive, fan-driven experiences that foster lasting connections between fans, teams, rights holders, and brands. Fanpictor's digital toolkit enables clients' marketing and creative teams to develop unique campaigns tailored to specific events or series of games, collecting commercially validated data to assess the success of these initiatives and engagement levels across different demographics. All solutions are fully white-labeled and can be accessed through dedicated event apps or integrated into existing brand, league, or team apps. Additionally, Fanpictor helps create venue-specific choreographies to enhance fan experiences.

Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.

Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.

Medyria AG is a Swiss medical technology company focused on developing innovative sensor-based systems for catheter navigation and sensing in cardiovascular procedures. Founded in 2012 and based in Winterthur, Switzerland, Medyria engineers devices that enhance the safety and effectiveness of endovascular surgeries. Its product lineup includes a catheter positioning system that eliminates the need for X-rays and contrast dyes, a blood flow measurement system known as Flowcath, and the Trackcath technology, which processes flow data to facilitate catheter tracking. These technologies aim to streamline minimally invasive procedures, reduce potential complications, and lower overall treatment costs, thereby supporting healthcare professionals in delivering optimal patient care. Medyria operates with a commitment to advancing medical devices that prioritize patient safety and procedural efficiency.

Bluetector AG is a Swiss company specializing in the manufacture of wastewater treatment machinery, particularly focusing on the treatment of manure and biogas digestate. Established in 2012 and based in Root, Switzerland, Bluetector produces innovative wastewater treatment containers and systems. The company's technology provides a cost-effective solution for farms struggling with excess manure by converting it into clean water, thus eliminating the need for costly transport over long distances. By utilizing a containerized filtering system based on biological purification methods, Bluetector offers a sustainable approach to managing liquid waste, allowing environmental companies to clean and reuse wastewater in an environmentally friendly manner. Additionally, the company is involved in constructing and renovating municipal wastewater treatment plants, further contributing to effective wastewater management solutions.

Ampard AG is a Swiss company based in Zurich that specializes in the development and marketing of energy management systems across Europe. Since its inception in 2011, Ampard has focused on optimizing the control of distributed renewable power plants and implementing demand response solutions. The company's flagship product, the AMPARD energy management system, is designed for residential and small commercial customers, enabling the efficient management of renewable assets and storage systems. By facilitating the creation of virtual power plants and integrating various devices for demand response, Ampard is recognized as a leader in energy innovation, particularly in the realm of decentralized power management.

iMusician Digital AG is a Swiss-based online platform founded in 2007, dedicated to empowering musicians in managing, selling, and monetizing their music. Located in Zurich, the company offers a comprehensive suite of tools that enables artists to distribute their music across major streaming services and sales platforms. iMusician focuses on simplifying the process for musicians by providing real-time sales tracking and copyright management, allowing them to concentrate on their creative work. With a small, passionate international team, iMusician Digital strives to support artists in navigating the complexities of the music industry and maximizing their revenue potential.

Climeworks AG is a Swiss company founded in 2009 that specializes in developing and commercializing technology for capturing carbon dioxide (CO2) directly from the atmosphere. The company operates modular direct air capture plants that utilize filters and primarily low-grade heat as an energy source to extract CO2. This captured CO2 is then supplied to various industries, including commercial agriculture, food and beverage, energy, and automotive. Clients employ this atmospheric CO2 for applications such as carbonated drinks, carbon-neutral hydrocarbon fuels, and materials. Climeworks also supports businesses in achieving their climate objectives by providing solutions for reversing emissions and safely storing the captured CO2, contributing to global efforts to combat climate change.

ProteoMediX is a healthcare company based in Zurich-Schlieren, Switzerland, focused on transforming the diagnosis of prostate cancer. The company has developed innovative biomarker signatures that enhance the accuracy of prostate cancer diagnosis, prognosis, and therapy management. Its lead product, Proclarix®, is a blood-based test panel and risk score that is currently available in Europe. The biomarkers created by ProteoMediX provide improved discrimination between aggressive and indolent forms of cancer, surpassing existing clinical standards. This advancement enables physicians to make more informed treatment decisions for their patients, ultimately aiming to improve outcomes in prostate cancer care.

Uepaa AG, based in Zurich, Switzerland, specializes in peer-to-peer communication technology for mobile devices. Founded in 2012 by Mathias Haussmann and Dr. Franck Legendre, the company has developed an innovative software solution that allows mobile applications to establish direct connections, even in the absence of cellular or internet coverage. Its flagship product, the Uepaa! Safety app, launched in 2013, is designed to provide safety protection for lone workers and field employees by enabling features such as accident detection and emergency alerts. This app has become an industry standard for mobile-based safety solutions, serving thousands of users and meeting the growing demand for enhanced worker safety in various environments. Uepaa AG's technology platform, known as Proximity SDK p2pkit, allows devices to communicate and share information when in close proximity, further enhancing its applications in safety and emergency response.

Zkipster GmbH is an event management platform based in Zurich, Switzerland, founded in 2009. The company specializes in providing software solutions for live, virtual, and hybrid events, enabling seamless event planning and execution. Zkipster's offerings include powerful tools for guest management, custom communications via email, SMS, and WhatsApp, as well as online and offline event check-in. The platform also features real-time session and capacity management, dynamic seating charts, and QR code integration, facilitating efficient guest interactions while minimizing contact. With its innovative zFace technology, a picture matching search engine integrated into the guest list solution, Zkipster is trusted by global brands and renowned organizations to enhance event experiences and foster relationships with guests.

Arviem AG is a provider of global trade monitoring and management services, headquartered in Rotkreuz, Switzerland. The company specializes in cargo monitoring as a fully managed service, offering in-transit security and quality monitoring for shipments across land, sea, and air. Arviem’s solutions include real-time location tracking and condition monitoring, ensuring clients receive independent and reliable data regarding their cargo. Its advisory services encompass business consulting, system integration, and compliance, assisting clients in optimizing their supply chains. The company caters to various sectors, including consumer products, pharmaceuticals, chemicals, and logistics, serving clients in Europe, Asia, and the Americas, as well as importers, exporters, and logistics providers. Through strategic partnerships, Arviem enhances its service offerings and remains dedicated to delivering effective supply chain visibility and risk management solutions.

MySwissChocolate AG, established in 2010 and headquartered in Root, Switzerland, specializes in the production and marketing of chocolates. The company operates an online platform that allows users to design and purchase custom-made chocolates. MySwissChocolate's products are available both domestically in Switzerland and internationally, catering to a global market through its e-commerce channels.

Creoptix AG is a Swiss company specializing in the development of optical instruments and consumables for label-free analysis of molecular interactions, primarily serving the drug discovery industry. Founded in 2009 and headquartered in Wädenswil, Switzerland, with an additional office near Boston, Creoptix focuses on next-generation bioanalytical instruments that leverage proprietary sensor and microfluidics technology. Their flagship product, the Creoptix WAVEsystem, utilizes Grating-Coupled Interferometry (GCI) technology to offer high sensitivity and resolution for real-time analysis of biological interactions, accommodating various samples, including small molecules, peptides, and biologics in complex biofluids like serum and plasma. The company also provides instrument sets for fragment-based screening and binding analysis, versatile sensors for carboxyl-coupling of various molecules, and integrated software for assay setup and data evaluation, catering to both industry and academic research needs.

SWISSto12 SA is a Swiss company that specializes in the manufacture and supply of radio frequency (RF) and microwave components and systems. Founded in 2011 as a spin-off from the Swiss Federal Institute of Technology in Lausanne, the company is based in Renens, Switzerland, with additional offices in Santa Clara, California, and Rehovot, Israel. SWISSto12 offers a range of products including various types of horn antennas, airborne antenna arrays, waveguide antennas, and custom-designed antennas and filters. The company is known for its innovative use of metal-coated 3D printing technology, which enhances design flexibility while reducing costs, lead times, and weight. Its offerings extend to polymer and metal waveguide products, as well as integration and testing services. SWISSto12 serves clients in satellite communications, airborne satellites, and research centers, and is also developing software solutions for material properties extraction.

iMusician Digital AG is a Swiss-based online platform founded in 2007, dedicated to empowering musicians in managing, selling, and monetizing their music. Located in Zurich, the company offers a comprehensive suite of tools that enables artists to distribute their music across major streaming services and sales platforms. iMusician focuses on simplifying the process for musicians by providing real-time sales tracking and copyright management, allowing them to concentrate on their creative work. With a small, passionate international team, iMusician Digital strives to support artists in navigating the complexities of the music industry and maximizing their revenue potential.

Aeon Scientific AG is a medical device company based in Schlieren, Switzerland, specializing in the development of innovative medical equipment utilizing patented electromagnetic steering technology. Founded in 2010, the company focuses on enhancing the effectiveness and safety of medical procedures, particularly in the field of electrophysiology. Its flagship product, Cmag, is a magnetic catheter steering system designed to assist physicians during catheter ablation procedures for arrhythmias, such as atrial fibrillation, by enabling precise manipulation of the ablation catheter within the heart using magnetic fields. Aeon Scientific aims to create a range of next-generation medical tools and comprehensive instrument toolkits for various medical applications, fostering partnerships with other medical device manufacturers to drive innovation in healthcare. The company is committed to making medical procedures safer, less invasive, and more cost-effective.

Bluetector AG is a Swiss company specializing in the manufacture of wastewater treatment machinery, particularly focusing on the treatment of manure and biogas digestate. Established in 2012 and based in Root, Switzerland, Bluetector produces innovative wastewater treatment containers and systems. The company's technology provides a cost-effective solution for farms struggling with excess manure by converting it into clean water, thus eliminating the need for costly transport over long distances. By utilizing a containerized filtering system based on biological purification methods, Bluetector offers a sustainable approach to managing liquid waste, allowing environmental companies to clean and reuse wastewater in an environmentally friendly manner. Additionally, the company is involved in constructing and renovating municipal wastewater treatment plants, further contributing to effective wastewater management solutions.